Heat-killed Lactobacillus casei confers broad protection against influenza A virus primary infection and develops heterosubtypic immunity against future secondary infection-Reference-Cited by-同舟云学术

Heat-killed Lactobacillus casei confers broad protection against influenza A virus primary infection and develops heterosubtypic immunity against future secondary infection

Published:2017-12 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Jung Yu-Jin,Lee Young-Tae,Ngo Vu Le,Cho Young-Hee,Ko Eun-Ju,Hong Sung-Moon,Kim Ki-Hye,Jang Ji-Hun,Oh Joon-Suk,Park Min-Kyung,Kim Cheol-Hyun,Sun Jun^ORCID,Kang Sang-Moo

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-17487-8.pdf

Reference48 articles.

1. Drouault, S. & Corthier, G. Health effects of lactic acid bacteria ingested in fermented milk. Veterinary research 32, 101–117, https://doi.org/10.1051/vetres:2001115 (2001).

2. Hosoi, T. et al. Cytokine responses of human intestinal epithelial-like Caco-2 cells to the nonpathogenic bacterium Bacillus subtilis (natto). International journal of food microbiology 82, 255–264 (2003).

3. Maeda, N. et al. Oral administration of heat-killed Lactobacillus plantarum L-137 enhances protection against influenza virus infection by stimulation of type I interferon production in mice. International immunopharmacology 9, 1122–1125, https://doi.org/10.1016/j.intimp.2009.04.015 (2009).

4. Hancock, K. et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 361, 1945–1952, doi:NEJMoa090645310.1056/NEJMoa0906453 (2009).

5. Smith, L. R. et al. Phase 1 clinical trials of the safety and immunogenicity of adjuvanted plasmid DNA vaccines encoding influenza A virus H5 hemagglutinin. Vaccine 28, 2565–2572, doi:S0264-410X(10)00061-710.1016/j.vaccine.2010.01.029 (2010).

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacological mechanisms of Ma Xing Shi Gan Decoction in treating influenza virus-induced pneumonia: intestinal microbiota and pulmonary glycolysis;Frontiers in Pharmacology;2024-08-05

2. Dry Powder Inhaler Formulation of Lactobacillus rhamnosus GG Targeting Pseudomonas aeruginosa Infection in Bronchiectasis Maintenance Therapy;Pharmaceutics;2024-07-25

3. Oral Administration of Limosilactobacillus reuteri KBL346 Ameliorates Influenza Virus A/PR8 Infection in Mouse;Probiotics and Antimicrobial Proteins;2024-06-29

4. SIR+ models: accounting for interaction-dependent disease susceptibility in the planning of public health interventions;Scientific Reports;2024-06-05

5. The Influence of Probiotic Lactobacilli on COVID-19 and the Microbiota;Nutrients;2024-04-30